Comparative Efficacy of Brolucizumab in the Treatment of Neovascular Age-Related Macular Degeneration: A Systematic Literature Review and Network Meta-Analysis-Reference-Cited by-同舟云学术

Comparative Efficacy of Brolucizumab in the Treatment of Neovascular Age-Related Macular Degeneration: A Systematic Literature Review and Network Meta-Analysis

Published:2022-06-09 Issue:8 Volume:39 Page:3425-3448
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Finger Robert P.,Dennis Natalie,Freitas Rita,Quenéchdu Arthur,Clemens Andreas,Karcher Helene,Souied Eric H.

Funder

Novartis Pharma AG

Rheinische Friedrich-Wilhelms-Universität Bonn

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12325-022-02193-3.pdf

Reference41 articles.

1. Wykoff CC, Ou WC, Brown DM, et al. Randomized trial of treat-and-extend versus monthly dosing for neovascular age-related macular degeneration: 2-year results of the TREX-AMD study. Ophthalmol Retina. 2017;1(4):314–21. https://doi.org/10.1016/j.oret.2016.12.004.

2. Chakravarthy U, Adamis AP, Cunningham ET, et al. Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. Ophthalmology. 2006;113(9):1508.e1-25. https://doi.org/10.1016/j.ophtha.2006.02.064.

3. Sepahi S, Mohajeri SA, Hosseini SM, et al. Effects of crocin on diabetic maculopathy: a placebo-controlled randomized clinical trial. Am J Ophthalmol. 2018;190:89–98. https://doi.org/10.1016/j.ajo.2018.03.007.

4. Cook HL, Patel PJ, Tufail A. Age-related macular degeneration: diagnosis and management. Br Med Bull. 2008;85:127–49. https://doi.org/10.1093/bmb/ldn012.

5. Mantel I. Optimizing the anti-VEGF treatment strategy for neovascular age-related macular degeneration: from clinical trials to real-life requirements. Transl Vis Sci Technol. 2015;4(3):6. https://doi.org/10.1167/tvst.4.3.6.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switching to Intravitreal Brolucizumab after Ranibizumab or Aflibercept Using Treat and Extend Regimen for Neovascular Age-Related Macular Degeneration in Japanese Patients: 1-Year Results and Factors Associated with Treatment Responsiveness;Journal of Clinical Medicine;2024-07-26

2. Efficacy and safety of faricimab for neovascular age-related macular degeneration: a systematic review and network meta-analysis;BMJ Open Ophthalmology;2024-07

3. Intravitreal treatments for exudative maculopathies: the efficacy/durability dilemma;Minerva Ophthalmology;2024-04

4. Intravitreal Brolucizumab for Chronic Central Serous Chorioretinopathy without Choroidal Neovascular Membrane – a Pilot Study;Seminars in Ophthalmology;2024-01-25

5. Crosstalk Between Microglia and Müller Glia in the Age-Related Macular Degeneration: Role and Therapeutic Value of Neuroinflammation;aging and disease;2024